SARS-CoV-2 Nucleocapsid Antibody (3868) - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-07070
Key Product Details
Species Reactivity
SARS-CoV-2
Applications
ELISA, Immunocytochemistry/ Immunofluorescence, Sandwich ELISA
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # 3868
Format
BSA Free
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed using a recombinant, full-length nucleoprotein.
Specificity
Specific for the nucleocapsid of Covid-19 virus. Cross reacts with SARS. These antibodies are non-reactive with: Influenza A, Influenza B, Adenovirus and MERS.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Description
This antibody is purified from ascites fluid or culture medium by protein A chromatography or sequential differential precipitations.
Scientific Data Images for SARS-CoV-2 Nucleocapsid Antibody (3868) - BSA Free
Sandwich ELISA: SARS-CoV-2 Nucleocapsid Antibody (3868) [NBP3-07070] - Sandwich ELISA for SARS-CoV-2 Nucleocapsid Matched Pair Antibodies. A sandwich ELISA was performed using SARS-CoV-2 Nucleocapsid antibody (NBP3-07038, 2ug/ml) as capture antibody, a nucleocapsid recombinant protein as the binding protein, and the anti-SARS-CoV-2 Nucleocapsid antibody (NBP3-07070, 0.5ug/ml) as the detection antibody. Secondary: Goat anti-mouse IgG HRP conjugate at 1:20000 dilution. Detection range is from 0.03 ng to 300 ng. EC50 = 4.27 ng
Sandwich ELISA: SARS-CoV-2 Nucleocapsid Antibody (3868) [NBP3-07070] - Sandwich ELISA for SARS-CoV-2 Nucleocapsid Antibodies. A sandwich ELISA was performed using SARS-CoV-2 Nucleocapsid antibody (NBP3-07039, 2ug/ml) as capture antibody, the Nucleocapsid recombinant protein as the binding protein, and the anti-SARS-CoV-2 Nucleocapsid antibody (NBP3-07068, 0.5ug/ml) as the detection antibody. Secondary: Goat anti-mouse IgG HRP conjugate at 1:20000 dilution. Detection range is from 0.03 ng to 300 ng. EC50 = 15.82 ng
Applications for SARS-CoV-2 Nucleocapsid Antibody (3868) - BSA Free
Application
Recommended Usage
ELISA
1:20-1:200
Immunocytochemistry/ Immunofluorescence
1:10-1:50
Application Notes
Sandwich ELISAs for SARS-CoV-2 Nucleocapsid Matched Pair Antibodies. A sandwich ELISA was performed using SARS-CoV-2 Nucleocapsid antibody (NBP3-07038, 2ug/ml) as capture antibody, a nucleocapsid recombinant protein as the binding protein, and the anti-SARS-CoV-2 Nucleocapsid antibody (NBP3-07070, 0.5ug/ml) as the detection antibody. Secondary: Goat anti-mouse IgG HRP conjugate at 1:20000 dilution. Detection range is from 0.03 ng to 300 ng. EC50 = 4.27 ng. A sandwich ELISA was performed using SARS-CoV-2 Nucleocapsid antibody (NBP3-07039, 2ug/ml) as capture antibody, the Nucleocapsid recombinant protein as the binding protein, and the anti-SARS-CoV-2 Nucleocapsid antibody (NBP3-07068, 0.5ug/ml) as the detection antibody. Secondary: Goat anti-mouse IgG HRP conjugate at 1:20000 dilution. Detection range is from 0.03 ng to 300 ng. EC50 = 15.82 ng.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS (0.01M, pH 7.2)
Format
BSA Free
Preservative
0.1% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C.
Background: SARS-CoV-2 Nucleocapsid
Following SARS-CoV-2 infection, B cells and T cells display an immune response against nucleocapsid protein and nucleocapsid-specific neutralizing antibodies are produced (5). Interestingly, a study of patients who have recovered from COVID-19 revealed that there were no neutralizing antibodies against nucleocapsid protein present; however, a high presence against neutralizing spike RBD antibodies were detected (5).
References
1. Pillay T. S. (2020). Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein. Journal of Clinical Pathology. https://doi.org/10.1136/jclinpath-2020-206658
2. Malik Y. A. (2020). Properties of Coronavirus and SARS-CoV-2. The Malaysian Journal of Pathology.
3. Zhu, G., Zhu, C., Zhu, Y., & Sun, F. (2020). Minireview of progress in the structural study of SARS-CoV-2 proteins. Current Research in Microbial Sciences. https://doi.org/10.1016/j.crmicr.2020.06.003
4. Uniprot (P0DTC9)
5. Shah, V. K., Firmal, P., Alam, A., Ganguly, D., & Chattopadhyay, S. (2020). Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2020.01949
Alternate Names
2019-nCoV N Protein, 2019-nCoV Nucleocapsid Protein, COVID-19 N protein, COVID-19 nucleocapsid protein, Human coronavirus Nucleoprotein, nucleocapsid phosphoprotein, Nucleocapsid protein, Nucleoprotein, ORF9; structural protein, SARS-CoV-2, SARS-CoV-2 Nucleocapsid protein, SARS-CoV-2 N protein, SARSCoV2 Nucleoprotein, Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Protein
Gene Symbol
N
Additional SARS-CoV-2 Nucleocapsid Products
Product Documents for SARS-CoV-2 Nucleocapsid Antibody (3868) - BSA Free
Product Specific Notices for SARS-CoV-2 Nucleocapsid Antibody (3868) - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...